These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 8343002)
21. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382 [TBL] [Abstract][Full Text] [Related]
22. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. Khare MD; Bukhari SS; Swann A; Spiers P; McLaren I; Myers J J Infect; 2007 Feb; 54(2):146-50. PubMed ID: 16678904 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824 [TBL] [Abstract][Full Text] [Related]
24. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites. Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065 [TBL] [Abstract][Full Text] [Related]
26. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Safdar N; Maki DG Chest; 2005 Aug; 128(2):489-95. PubMed ID: 16100130 [TBL] [Abstract][Full Text] [Related]
27. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Civetta JM; Hudson-Civetta J; Ball S Crit Care Med; 1996 Oct; 24(10):1660-5. PubMed ID: 8874302 [TBL] [Abstract][Full Text] [Related]
28. Frequency of infections associated with implanted systems vs cuffed, tunneled Silastic venous catheters in patients with acute leukemia. Severien C; Nelson JD Am J Dis Child; 1991 Dec; 145(12):1433-8. PubMed ID: 1669674 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263 [TBL] [Abstract][Full Text] [Related]
30. Role of culturing from the tip and the tunneled segment of the catheters in tunneled catheter infection. Koç O; Peynircioğlu B; Cil BE Diagn Interv Radiol; 2008 Dec; 14(4):228-32. PubMed ID: 19061170 [TBL] [Abstract][Full Text] [Related]
31. Do central venous catheters have advantages over arteriovenous fistulas or grafts? Quarello F; Forneris G; Borca M; Pozzato M J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685 [TBL] [Abstract][Full Text] [Related]
32. Failure of silver impregnated subcutaneous cuffs to prevent intravascular catheter infections in cancer patients. Girvent M; Sitges-Serra A Ann Surg; 1995 Jan; 221(1):115-6. PubMed ID: 7826153 [No Abstract] [Full Text] [Related]
33. Prevention of intravascular catheter-related infections. Mermel LA Ann Intern Med; 2000 Mar; 132(5):391-402. PubMed ID: 10691590 [TBL] [Abstract][Full Text] [Related]
34. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Andrivet P; Bacquer A; Ngoc CV; Ferme C; Letinier JY; Gautier H; Gallet CB; Brun-Buisson C Clin Infect Dis; 1994 Feb; 18(2):199-206. PubMed ID: 8161627 [TBL] [Abstract][Full Text] [Related]